Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /application/attributes Disallow: /application/authentication Disallow: /application/bootstrap Disallow: /application/blocks Disallow: /application/files Disallow: /application/config Disallow: /application/controllers Disallow: /application/elements Disallow: /application/helpers Disallow: /application/jobs Disallow: /application/languages Disallow: /application/mail Disallow: /application/models Disallow: /application/page_types Disallow: /application/single_pages Disallow: /application/tools Disallow: /application/views Disallow: /ccm/system/captcha/picture Disallow: /fr Sitemap: |
Title | Allucent: CRO Bringing Innovation to Biopharma |
Description | Shining a light on your next Allucent, a clinical research organization striving to bring new therapies to light by solving distinct challenges of small and mid-sized biopharma |
Keywords | N/A |
WebSite | allucent.com |
Host IP | 199.60.103.198 |
Location | Canada |
Site | Rank |
US$11,039,576
Last updated: 2023-05-18 06:44:44
allucent.com has Semrush global rank of 958,760. allucent.com has an estimated worth of US$ 11,039,576, based on its estimated Ads revenue. allucent.com receives approximately 1,273,798 unique visitors each day. Its web server is located in Canada, with IP address 199.60.103.198. According to SiteAdvisor, allucent.com is safe to visit. |
Purchase/Sale Value | US$11,039,576 |
Daily Ads Revenue | US$10,191 |
Monthly Ads Revenue | US$305,712 |
Yearly Ads Revenue | US$3,668,536 |
Daily Unique Visitors | 84,920 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
allucent.com. | A | 300 | IP: 199.60.103.198 |
allucent.com. | A | 300 | IP: 199.60.103.98 |
allucent.com. | NS | 86400 | NS Record: ns-1354.awsdns-41.org. |
allucent.com. | NS | 86400 | NS Record: ns-1881.awsdns-43.co.uk. |
allucent.com. | NS | 86400 | NS Record: ns-427.awsdns-53.com. |
allucent.com. | NS | 86400 | NS Record: ns-653.awsdns-17.net. |
allucent.com. | MX | 300 | MX Record: 0 allucent-com.mail.protection.outlook.com. |
allucent.com. | TXT | 3600 | TXT Record: v=spf1 +ip4:208.185.102.46 include:cato-sms.com include:spf-us.emailsignatures365.com include:spf.emailsignatures365.com include:spf.protection.outlook.com include:_spf.salesforce.com ~all |
ENGLISH FRANCAIS Services Services Overview Clinical Trial Operations Protocol Development and Study Design Feasibility and Study Start Up Patient Recruitment Project Management Clinical Operations Centralized Monitoring Decentralized Clinical Trials (DCT) Centralized eTMF Medical Services Regulatory and Drug Development Consulting Clinical Strategy Nonclinical Chemistry, Manufacturing, and Controls (CMC) Regulatory Affairs GxP Strategy Consulting Publishing and Submissions Medical Writing Government and Public Health Services Biometrics Biostatistics and Statistical Programming Data Management Clinical Pharmacology Modeling Simulation Clinical Pharmacology Integrated Drug Development Model Informed Dose & Drug Development (MIDD) Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD) DMPK and Translational Discovery and Development Therapeutic Expertise Therapeutic Expertise Overview By Subject Oncology and Hematology Rare Diseases and Orphan Drugs Infectious Disease and |
HTTP/1.1 301 Moved Permanently Date: Thu, 26 May 2022 20:16:02 GMT Connection: keep-alive Location: https://allucent.com/ Cache-Control: s-maxage=3600,max-age=120 Strict-Transport-Security: max-age=31536000 X-Hs-Https-Only: worker Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=%2Btg910Tsu2aVQuC9QB7DZiU7EO6QavbRwxIuwdv6bjvOQsJ0eDOOflEAxQK4XGQDeE30NgGg%2BIYjf8JX5S%2BlYdlY42Of%2BuFbQT7ztVRweJz0Aiz9KCIHtDsdNZdL%2FQ%3D%3D"}],"group":"cf-nel","max_age":604800} NEL: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800} Set-Cookie: __cfruid=62a84b2fd2ddcb8766e3a6836d57f7bb13885e6a-1653596162; path=/; domain=.allucent.com; HttpOnly Server: cloudflare CF-RAY: 71192fb16f6975b3-DME HTTP/2 301 date: Thu, 26 May 2022 20:16:03 GMT location: https://www.allucent.com cf-ray: 71192fb28df29d34-DME cache-control: no-transform, max-age=120 expires: Thu, 26 May 2022 20:18:03 GMT strict-transport-security: max-age=31536000 vary: Accept-Encoding cf-cache-status: MISS access-control-allow-credentials: false expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" x-hubspot-correlation-id: ca64d33e-8d59-4008-9d5f-d61d2ec65a51 x-trace: 2B2EB183FFF1D05201BF6C4ADACFD5020770970B36000000000000000000 report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Cz8yoUsGzSrbpJgde55DYpWPHed4aNtbdSLtS6n%2BRh9TzjyywnGIhFmIYNF3TnR5D%2FzSmvu9UGUwa8tL%2FsbWXzJ6mhqy0RZm46%2BDEyj5VEvY%2FL8KBN8bAn6URHkuEQ%3D%3D"}],"group":"cf-nel","max_age":604800} nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800} set-cookie: __cfruid=39d758b34c2b3545232e3ad274e857747435eec5-1653596163; path=/; domain=.allucent.com; HttpOnly; Secure; SameSite=None server: cloudflare HTTP/2 200 date: Thu, 26 May 2022 20:16:04 GMT content-type: text/html; charset=UTF-8 content-length: 35294 cache-control: s-maxage=14400, max-age=0 etag: "8d8555ee645ad2f852514ed724f2d912" last-modified: Sun, 22 May 2022 00:14:40 GMT link: ; rel=preload; as=script,; rel=preload; as=script strict-transport-security: max-age=31536000 content-security-policy: upgrade-insecure-requests edge-cache-tag: CT-71266385468,P-21756997,CW-70793948525,CW-70794059035,CW-70795336025,CW-70795701539,CW-71276053107,E-70793762588,E-70794058285,E-70794059028,E-70794203031,E-70794285912,E-70794497391,E-71272529971,E-71274363548,E-71274603433,RA-70793762582,RA-70795210859,RA-70795394120,PGS-ALL,SW-4,GC-71276801168,GC-71276931913,TS-71274486189 referrer-policy: no-referrer-when-downgrade x-hs-cache-config: BrowserCache-5s-EdgeCache-180s x-hs-cache-control: s-maxage=14400, max-age=0 x-hs-cf-cache-status: REVALIDATED x-hs-combine-css: Disabled x-hs-content-id: 71266385468 x-hs-hub-id: 21756997 x-hs-prerendered: Sun, 22 May 2022 00:14:40 GMT x-powered-by: HubSpot expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=HQF4J%2FVsGYdlfCZO%2BLVh4361%2FjKbrhI1yYtXynaV7fvEpuwDVGA0vBypkp3BmjxflvTyIQfT8gyhgCzbwp28Ctq6HFtSANANiVq9mb015p%2F9R6fuyjIdQUI%2F12qP5tLUoFdsLzk4PHITCTQpRGk%3D"}],"group":"cf-nel","max_age":604800} nel: {"success_fraction":0.01,"report_to":"cf-nel","max_age":604800} set-cookie: __cfruid=3116f28568266d180732ed5cbf37e3ba86a25956-1653596164; path=/; domain=.www.allucent.com; HttpOnly; Secure; SameSite=None server: cloudflare cf-ray: 71192fb77d053769-HEL |
Domain Name: ALLUCENT.COM Registry Domain ID: 2019676513_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-03-28T17:30:25Z Creation Date: 2016-04-07T14:55:12Z Registry Expiry Date: 2023-04-07T14:55:12Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1354.AWSDNS-41.ORG Name Server: NS-1881.AWSDNS-43.CO.UK Name Server: NS-427.AWSDNS-53.COM Name Server: NS-653.AWSDNS-17.NET DNSSEC: unsigned >>> Last update of whois database: 2022-05-26T21:22:12Z <<< |